DarioHealth Corp.
DarioHealth Corp. (DRIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DRIO · as of Jun 8, 2026
Key Statistics
Explore DarioHealth Corp. Data
drio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 88.9%
The DRIO analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $12.50, representing +66.23% upside from the current price of $7.52.
Competitors & Peers
drio competitorsDRIO
ABSI
AVNS
FLGT
INNV
MYGNStock Performance
Full HistoryAbout DarioHealth Corp.
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health soluti…
what is dariohealth corp. · drio stock overview · dariohealth corp. company profile · who is dariohealth corp. ceo · drio NASDAQ · dariohealth corp. headquarters · dariohealth corp. business segments
About Stock Overview & Key Data
DarioHealth Corp. (DRIO) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Mar 14, 2016. As of the latest trading session, DRIO stock price is $7.52, with a market capitalization of $55.0M. The stock has returned -47.92% over the past 12 months and -34.09% year-to-date.
According to 9 Wall Street analysts, the consensus rating for DarioHealth Corp. stock is Buy, with an average 12-month price target of $12.50. In fiscal year 2025, DarioHealth Corp. reported revenue of $22.4M and net income of -$41.7M. For detailed data — including DarioHealth Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, DarioHealth Corp. (DRIO) stock price is $7.52. The stock is traded on NASDAQ under the ticker symbol DRIO. The 52-week range is $5.93 – $17.74.